The ACCROBAT I study: Three-year follow-up of a prospective phase II study with neoadjuvant TPF before bioradiotherapy for stage III-IV unresectable squamous cell head and neck cancer.
2014 ◽
Vol 32
(15_suppl)
◽
pp. e17004-e17004
Keyword(s):
Phase Ii
◽